Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
Income from Continuing Operations
Edwards Lifesciences Corp
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Edwards Lifesciences Corp
NYSE:EW
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Edwards Lifesciences Corp's Income from Continuing Operations?
Income from Continuing Operations
1.4B
USD
Based on the financial report for Mar 31, 2024, Edwards Lifesciences Corp's Income from Continuing Operations amounts to 1.4B USD.
What is Edwards Lifesciences Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
17%
Over the last year, the Income from Continuing Operations growth was -5%. The average annual Income from Continuing Operations growth rates for Edwards Lifesciences Corp have been 18% over the past three years , 12% over the past five years , and 17% over the past ten years .